Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?

被引：8

作者：

Ciccarese, Chiara ^{[1
]}

Montironi, Rodolfo ^{[2
]}

Fiorentino, Michelangelo ^{[3
]}

Martignoni, Guido ^{[4
,5
]}

Brunelli, Matteo ^{[4
]}

Iacovelli, Roberto ^{[1
]}

Lopez-Beltran, Antonio ^{[6
,7
]}

Cheng, Liang ^{[8
]}

Scarpelli, Marina ^{[2
]}

Moch, Holger ^{[9
]}

Tortora, Giampaolo ^{[1
]}

Massari, Francesco ^{[10
]}

机构：

[1] Univ Verona, Azienda Osped Univ Integrata, Med Oncol, Verona, Italy

[2] Polytech Univ Marche Reg, Sch Med, AOU Osped Riuniti, Sect Pathol Anat, Ancona, Italy

[3] St Orsola Marcello Malpighi Hosp, Addarii Inst Oncol, Pathol Serv, Bologna, Italy

[4] Univ Verona, AOUI, Dept Pathol & Diagnost, Verona, Italy

[5] Pederzoli Hosp, Anat Pathol, Verona, Italy

[6] Univ Cordoba, Med Sch, Dept Surg & Pathol, Cordoba, Spain

[7] Champalimaud Clin Ctr, Lisbon, Portugal

[8] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA

[9] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland

[10] St Orsola Marcello Malpighi Hosp, Div Oncol, Bologna, Italy

来源：

CURRENT DRUG METABOLISM | 2017年 / 18卷 / 08期

关键词：

Prostate cancer; mCRPC; circulating tumor cells; CTCs; biomarker; malignancy; INCREASED SURVIVAL; PERIPHERAL-BLOOD; ABIRATERONE; DOCETAXEL; ENZALUTAMIDE; MITOXANTRONE; PREDNISONE; AMPLIFICATION; COUNTS; MARKER;

D O I：

10.2174/1389200218666170518163549

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Background: Prostate cancer is a common malignancy with highly molecular heterogeneity responsible for a wide spectrum of clinical behavior. To date, several treatment options are available, whose selection is currently based mainly on clinical criteria. Given the weakness of conventional imaging and PSA assay, the identification of a prognostic and predictive biomarker for choosing the appropriate treatment and monitoring its efficacy is a very topical issue in prostate cancer management. Circulating tumor cells (CTCs) have substantial promise for early tumor diagnosis, disease recurrence and metastatic spread monitoring as well as for biological tumor characterization, thus representing a reliable translational real-time biomarkers of prostate cancer. Conclusion: This paper summarized the main data available about CTCs detection, their prognostic value, and their potential predictive role for metastatic prostate cancer patients management.

引用

页码：692 / 699

页数：8

共 51 条

[1] The Molecular Taxonomy of Primary Prostate Cancer [J].

Abeshouse, Adam ;

Ahn, Jaeil ;

Akbani, Rehan ;

Ally, Adrian ;

Amin, Samirkumar ;

Andry, Christopher D. ;

Annala, Matti ;

Aprikian, Armen ;

Armenia, Joshua ;

Arora, Arshi ;

Auman, J. Todd ;

Balasundaram, Miruna ;

Balu, Saianand ;

Barbieri, Christopher E. ;

Bauer, Thomas ;

Benz, Christopher C. ;

Bergeron, Alain ;

Beroukhim, Rameen ;

Berrios, Mario ;

Bivol, Adrian ;

Bodenheimer, Tom ;

Boice, Lori ;

Bootwalla, Moiz S. ;

dos Reis, Rodolfo Borges ;

Boutros, Paul C. ;

Bowen, Jay ;

Bowlby, Reanne ;

Boyd, Jeffrey ;

Bradley, Robert K. ;

Breggia, Anne ;

Brimo, Fadi ;

Bristow, Christopher A. ;

Brooks, Denise ;

Broom, Bradley M. ;

Bryce, Alan H. ;

Bubley, Glenn ;

Burks, Eric ;

Butterfield, Yaron S. N. ;

Button, Michael ;

Canes, David ;

Carlotti, Carlos G. ;

Carlsen, Rebecca ;

Carmel, Michel ;

Carroll, Peter R. ;

Carter, Scott L. ;

Cartun, Richard ;

Carver, Brett S. ;

Chan, June M. ;

Chang, Matthew T. ;

Chen, Yu .

CELL, 2015, 163 (04) :1011-1025

[2] Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].

Allard, WJ ;

Matera, J ;

Miller, MC ;

Repollet, M ;

Connelly, MC ;

Rao, C ;

Tibbe, AGJ ;

Uhr, JW ;

Terstappen, LWMM .

CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904

[3]

[Anonymous], NAT REV UROL

[4]

[Anonymous], 2016, J CLIN ONCOL

[5]

[Anonymous], J CLIN ONCOL S

[6]

[Anonymous], SCI REP

[7] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].

Antonarakis, Emmanuel S. ;

Lu, Changxue ;

Wang, Hao ;

Luber, Brandon ;

Nakazawa, Mary ;

Roeser, Jeffrey C. ;

Chen, Yan ;

Mohammad, Tabrez A. ;

Chen, Yidong ;

Fedor, Helen L. ;

Lotan, Tamara L. ;

Zheng, Qizhi ;

De Marzo, Angelo M. ;

Isaacs, John T. ;

Isaacs, William B. ;

Nadal, Rosa ;

Paller, Channing J. ;

Denmeade, Samuel R. ;

Carducci, Michael A. ;

Eisenberger, Mario A. ;

Luo, Jun .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038

[8] Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer [J].

Attard, Gerhardt ;

Swermenhuis, Joost F. ;

Olmos, David ;

Reid, Alison H. M. ;

Vickers, Elaine ;

A'Hern, Roger ;

Levink, Rianne ;

Coumans, Frank ;

Moreira, Joana ;

Riisnaes, Ruth ;

Oommen, Nikhil Babu ;

Hawche, George ;

Jameson, Charles ;

Thompson, Emilda ;

Sipkema, Ronald ;

Carden, Craig P. ;

Parker, Christopher ;

Dearnaley, David ;

Kaye, Stan B. ;

Cooper, Colin S. ;

Molina, Arturo ;

Cox, Michael E. ;

Terstappen, Leon W. M. M. ;

de Bono, Johann S. .

CANCER RESEARCH, 2009, 69 (07) :2912-2918

[9]

Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095

[10] Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer [J].

Brown, RSD ;

Edwards, J ;

Dogan, A ;

Payne, H ;

Harland, SJ ;

Bartlett, JMS ;

Masters, JRW .

JOURNAL OF PATHOLOGY, 2002, 198 (02) :237-244

← 1 2 3 4 5 6 →